DPP4 Inhibitor Sitagliptin Enhances Lymphocyte Recruitment and Prolongs Survival in a Syngeneic Ovarian Cancer Mouse Model.

Unlike sDPP4 in circulation, there was a decreasing trend in DPP4 abundance in tumour tissue two weeks following the commencement of sitagliptin treatment ( Figure 1 D).

also in 47,180 other papers